54 related articles for article (PubMed ID: 24534359)
1. Long-Term Follow-Up of Tamoxifen Treatment and the Use of Imaging in Psammocarcinoma: A Case Report, Review of the Literature and Discussion of Diagnostic and Therapeutic Challenges.
Gideonsson I; Israelsson P; Strandberg SN; Ottander U
Curr Oncol; 2023 Nov; 30(12):10260-10271. PubMed ID: 38132381
[TBL] [Abstract][Full Text] [Related]
2. 18F-FDG PET/CT in assessment of paraneoplastic cerebellar degeneration as the first sign of occult fallopian tube serous cystadenocarcinoma: Case report.
Kalantari F; Schweighofer-Zwink G; Hecht S; Rendl G; Pirich C; Beheshti M
Rofo; 2024 Apr; ():. PubMed ID: 38626884
[No Abstract] [Full Text] [Related]
3. The role of metabolic tumor volume and total lesion glycolysis on ¹⁸F-FDG PET/CT in the prognosis of epithelial ovarian cancer.
Lee JW; Cho A; Lee JH; Yun M; Lee JD; Kim YT; Kang WJ
Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1898-906. PubMed ID: 24852188
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG PET/MRI and 18F-FDG PET/CT for the Management of Gynecological Malignancies: A Comprehensive Review of the Literature.
Allahqoli L; Hakimi S; Laganà AS; Momenimovahed Z; Mazidimoradi A; Rahmani A; Fallahi A; Salehiniya H; Ghiasvand MM; Alkatout I
J Imaging; 2023 Oct; 9(10):. PubMed ID: 37888330
[TBL] [Abstract][Full Text] [Related]
5. Low-Grade Serous Carcinoma of the Ovary: The Current Status.
Babaier A; Mal H; Alselwi W; Ghatage P
Diagnostics (Basel); 2022 Feb; 12(2):. PubMed ID: 35204549
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic performance of PET/CT and PET/MR in the management of ovarian carcinoma-a literature review.
Virarkar M; Ganeshan D; Gulati AT; Palmquist S; Iyer R; Bhosale P
Abdom Radiol (NY); 2021 Jun; 46(6):2323-2349. PubMed ID: 33175199
[TBL] [Abstract][Full Text] [Related]
7. Low-grade epithelial ovarian cancer: what a radiologist should know.
Elsherif S; Javadi S; Viswanathan C; Faria S; Bhosale P
Br J Radiol; 2019 Mar; 92(1095):20180571. PubMed ID: 30604635
[TBL] [Abstract][Full Text] [Related]
8. Systematic Review on the Accuracy of Positron Emission Tomography/Computed Tomography and Positron Emission Tomography/Magnetic Resonance Imaging in the Management of Ovarian Cancer: Is Functional Information Really Needed?
Suppiah S; Chang WL; Hassan HA; Kaewput C; Asri AAA; Saad FFA; Nordin AJ; Vinjamuri S
World J Nucl Med; 2017; 16(3):176-185. PubMed ID: 28670174
[TBL] [Abstract][Full Text] [Related]
9. An update on the role of PET/CT and PET/MRI in ovarian cancer.
Khiewvan B; Torigian DA; Emamzadehfard S; Paydary K; Salavati A; Houshmand S; Werner TJ; Alavi A
Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):1079-1091. PubMed ID: 28180966
[TBL] [Abstract][Full Text] [Related]
10. Increase in post-therapy tumor calcification on CT scan is not an indicator of response to therapy in low-grade serous ovarian cancer.
Ganeshan D; Bhosale P; Wei W; Ramalingam P; Mudasiru-Dawodu E; Gershenson D; Sun C; Iyer R
Abdom Radiol (NY); 2016 Aug; 41(8):1589-95. PubMed ID: 26969496
[TBL] [Abstract][Full Text] [Related]
11. Clinical and Survival Impact of FDG PET in Patients with Suspicion of Recurrent Ovarian Cancer: A 6-Year Follow-Up.
Rusu D; Carlier T; Colombié M; Goulon D; Fleury V; Rousseau N; Berton-Rigaud D; Jaffre I; Kraeber-Bodéré F; Campion L; Rousseau C
Front Med (Lausanne); 2015; 2():46. PubMed ID: 26258124
[TBL] [Abstract][Full Text] [Related]
12. The value of 18F-FDG PET/CT imaging combined with detection of CA125 and HE4 in the diagnosis of recurrence and metastasis of ovarian cancer.
Sun J; Cui XW; Li YS; Wang SY; Yin Q; Wang XN; Gu L
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7276-7283. PubMed ID: 32706065
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
[TBL] [Abstract][Full Text] [Related]
14. [F-18-FDG positron emission tomography in the diagnosis of ovarian recurrence. Comparison with CT scan and CA 125].
García Velloso MJ; Boán García JF; Villar Luque LM; Aramendía Beitia JM; López García G; Richter Echeverría JA
Rev Esp Med Nucl; 2003; 22(4):217-23. PubMed ID: 12846945
[TBL] [Abstract][Full Text] [Related]
15. PET/CT in the imaging of ovarian Cancer.
O'Connor OJ; Prakash P; Cronin CG; McDermott S; Blake MA
Front Biosci (Elite Ed); 2013 Jan; 5(1):141-53. PubMed ID: 23276977
[TBL] [Abstract][Full Text] [Related]
16. Utility of 18F-FDG PET/CT in follow-up of patients with low-grade serous carcinoma of the ovary.
Takeuchi S; Lucchini M; Schmeler KM; Coleman RL; Gershenson DM; Munsell MF; Macapinlac HA; Ramirez PT
Gynecol Oncol; 2014 Apr; 133(1):100-4. PubMed ID: 24534359
[TBL] [Abstract][Full Text] [Related]
17. Impact of positron emission tomography/computed tomography in the management of patients with epithelial ovarian carcinoma after treatment.
Nasu K; Abe W; Takai N; Tomonari K; Narahara H
Arch Gynecol Obstet; 2011 May; 283(5):1121-6. PubMed ID: 20574659
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
